Search

everythinglearnresearchcommunity

for

Search:↓

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

COVID-19 pneumonia may cause lasting lung damage like fibrosis.

A woman's liver problems improved after she stopped taking spironolactone.

Lack of functional CYLD in mice leads to early aging and cancer.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Mutant CDP/Cux protein causes hair defects and reduced male fertility in mice.

CDP is crucial for lung and hair follicle cell development.

Rac1 is essential for proper hair structure and color.

FoxN1 overexpression in young mice harms immune cell and skin development.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

sPLA2-X is crucial for normal hair growth and follicle health.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

The timing of when the gene Bmal1 is active affects aging and survival, with its absence during development, not adulthood, leading to premature aging.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Radiological findings help distinguish LAM, PLCH, and BHD to avoid invasive tests.

Not all hair loss patients need lab tests; patient history and physical exams are key to deciding who does.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

The Dfl mutation in mice causes poor sebaceous gland function and complete hair loss.